Home
Our Philosophy
Portfolio
Team
Media & Publications
Contact Us
Home
Our Philosophy
Buttons
Google Maps
Media & Publications
Videos
Team
Portfolio
News & Press
Contact Us
Home
Scotasian Capital
Portfolio
Public Company
Biogen
Biogen
Biogen
Biogen, Inc. (NASDAQ: BIIB) develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Scroll to top